NSEGeneral Updates5d ago · 9 Oct 2026, 03:58 pm

General Updates

Alivus Life Sciences Limited · ALIVUS

✦ AI SummaryRegulatory

Alivus Life Sciences Limited has received an order from the Central Goods & Service Tax Department for FY 2020-21 and FY 2021-22, with an amount of Rs. 25,61,400, along with penalty and interest, but the company claims no material impact on its financial operations.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alivus Life Sciences Limited has informed the Exchange about General Updates

Attachments (1)

📄

GLS_09102026155635_BSE_NSE_PressRelease_09102026_GST_Signed.pdf

pdf

Download →
View document text
October 9, 2026 To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS Dear Sir/Madam, Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“SEBI Listing Regulations”) Pursuant to Regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations) read with clause 20 of Para A of Part A of Schedule III of the LODR Regulations, the details of Intimation/Order received by the Company from Central Goods & Service Tax Department, Office of the Assistant Commissioner, Division-VIII, Ankleshwar, Vadodara-II Commissionerate is enclosed herewith as Annexure A. We request you to take the information on your records. Thanking You, Your Sincerely, For Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) Rudalf Corriea Company Secretary & Compliance Officer Encl.: as above Alivus Life Sciences Limited ( formerly Glenmark Life Sciences Limited ) Corporate Office: Registered Office: Technopolis Knowledge Park, A wingO, ffice No. 401 to 407, Plot No 170-172, Chandramouli Industrial Estate 4th Floor, Mahakali Caves Road, Andheri ( E), Mumba–i 400093 Mohol Bazarpeth, Solapur 413 213, India T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com Annexure A Particulars Details Name of the authority. Central Goods & Service Tax Department, Office of the Assistant Commissioner, Division-VIII, Ankleshwar, Vadodara-II Commissionerate. Nature and details of the Order dated 8th October 2026 passed under Section 74(1) of action(s) taken, or order(s) the CGST Act, 2017. passed. Date of receipt of direction or 8th October 2026 around 6.00 pm order, including any ad-interim or interim orders, or any other communication from the authority. Details of the violation(s) Order u/s 74(1) of the CGST Act, 2017 has been issued by the /contravention(s) committed or Central Goods & Service Tax Department for FY 2020-21 and alleged to be committed. FY 2021-22. Amount involved Rs. 25,61,400, along with penalty amounting to Rs. 25,61,400 and applicable interest. Impact on financial, operation or There is no material impact on financial, no impact on other activities of the listed operations or other activities of the Company due to the entity, quantifiable in monetary intimation of tax payable. This Order is currently appealable terms to the extent possible. & the Company will make an assessment to exercise the right to appeal.